Ubs Asset Management Americas Inc Genetron Holdings LTD Transaction History

Ubs Asset Management Americas Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.28 - $2.4 $43,146 - $80,899	-33,708 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$5.81 - $14.39 $138,045 - $341,906	-23,760 Reduced 41.34%	33,708 $205,000
Q3 2021 Nov 15, 2021	SELL	$11.55 - $20.3 $2.06 Million - $3.62 Million	-178,084 Reduced 75.6%	57,468 $795,000
Q2 2021 Aug 16, 2021	BUY	$17.9 - $23.29 $111,123 - $144,584	6,208 Added 2.71%	235,552 $4.74 Million
Q1 2021 May 14, 2021	SELL	$13.71 - $30.64 $12.5 Million - $28 Million	-914,256 Reduced 79.95%	229,344 $4.92 Million
Q4 2020 Mar 01, 2021	SELL	$9.31 - $14.0 $117,306 - $176,400	-12,600 Reduced 1.09%	1,143,600 $16 Million
Q3 2020 Nov 13, 2020	SELL	$9.1 - $15.81 $626,080 - $1.09 Million	-68,800 Reduced 5.62%	1,156,200 $13.8 Million
Q2 2020 Aug 14, 2020	BUY	$11.29 - $16.0 $13.8 Million - $19.6 Million	1,225,000 New	1,225,000 $14.8 Million

7.5K

Ticker GTH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 90,602,304
Description
Genetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. The company offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. It also provides in-vitro diagn...

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

Stay updated on Ubs Asset Management Americas Inc with notifications on news.